Siste forsøk

EudraCT Number: 2004-000518-37

Sponsor Protocol Number: 580299/013

Start Date: 2004-08-27

Sponsor Name: GlaxoSmithKline AS

Full Title: A phase III, double-blind, randomized, controlled study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ HPV-16/18 VLP/AS04 vaccine administered intramuscularly according t...

Medical condition: cervical cancer: the study is conducted in healthy female adolescents

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Female

Trial protocol: NO (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-000909-22

Sponsor Protocol Number: MDS-KET-2004-01

Start Date: 2004-08-27

Sponsor Name: MDS Pharma Services

Full Title: Comparative efficacy and tolerability of a topical ketoprofen TDS patch vs ketoprofen gel in the treatment of acute pain in soft-tissue injuries

Medical condition: Acute pain in soft-tissue injuries of lower limbs, except toes

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-000440-24

Sponsor Protocol Number: SDX-101-03

Start Date: 2004-08-24

Sponsor Name: Cephalon UK Limited

Full Title: A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination with Chlorambucil, and that of Chlorambucil alone, in Patients with Chronic ...

Medical condition: Chronic Lymphocytic Leukemia (CLL)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

EudraCT Number: 2004-001175-19

Sponsor Protocol Number: 102247

Start Date: 2004-08-24

Sponsor Name: GlaxoSmithKline

Full Title: A phase IIIb, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy, safety and immunogenicity of two doses of GSK Biologicals’ oral live attenua...

Medical condition: Two-dose immunization according to 0, 1 or 2-month schedule against rotavirus disease in healthy infants aged 6 to 14 weeks at the time of the first dose. Rotavirus infection.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: FI (Completed) CZ (Completed) IT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-000752-17

Sponsor Protocol Number: WO17299

Start Date: 2004-08-24

Sponsor Name: Hoffmann-La Roche Ltd/Inc/AG/Roche Global Development

Full Title: Phase II study of Herceptin® alone or in combination with a taxane, as a first-line treatment for patients with metastatic breast cancer, who have relapsed after receiving Herceptin® in the adjuvan...

Medical condition: Metastatic breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
			10027475

Population Age: Adults, Elderly

Gender: Female

Trial protocol: HU (Completed) ES (Completed) AT (Completed) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2004-000088-92

Sponsor Protocol Number: F7CBI-1600

Start Date: 2004-08-23

Sponsor Name: Novo Nordisk A/S

Full Title: A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Recombinant Factor VIIa (NovoSeven®/Niastase®) with Brain Cont...

Medical condition: Contusive Brain Injury

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10052346		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-001098-25

Sponsor Protocol Number: NAC-E-21

Start Date: 2004-08-23

Sponsor Name: Zambon SA

Full Title: N-Acetylcisteine (NAC) effect on the inmunologycal system

Medical condition: Postmenopausal health woman aged more than 50 years

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001103-35

Sponsor Protocol Number: NSGO -EC - 0302

Start Date: 2004-08-20

Sponsor Name: Nordic Society for Gynecologic Oncology

Full Title: Exemestane in Advanced or Recurrent Endometrial Carcinoma. A multicentre non-randomized Phase II study

Medical condition: Advanced or recurrent endometrial carcinoma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DK (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001308-11

Sponsor Protocol Number: F1D-XM-HGLW

Start Date: 2004-08-19

Sponsor Name: Lilly.S.A.

Full Title: Optimal Treatment Duration with Olanzapine following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies

Medical condition: to compare the efficacy in the prevention of relapse to manic, depressive, or mixed episodes in two groups of bipolar I patients

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10037175 - Psychiatric disorders	10004939	Bipolar I disorder	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-000483-27

Sponsor Protocol Number: PRA/BIA-2093-302

Start Date: 2004-08-19

Sponsor Name: BIAL - Portela & Ca, S.A.

Full Title: Efficacy and safety of BIA 2-093 as adjunctive therapy for refractory partial seizures in a double-blind, randomised, placebo-controlled, parallel-group, multicentre clinical trial.

Medical condition: Refractory partial epilepsy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) ES (Completed) DK (Completed)

Trial results: View results

Siste forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner